Prognostic Significance of CYCLIND1 and E-Cadherin in Patients with Esophageal Squamous Cell Carcinoma: Multiinstitutional Retrospective Analysis
- 1 June 2001
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 192 (6) , 708-718
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalitiesInternational Journal of Cancer, 1999
- Expression of E-Cadherin, α-Catenin, β-Catenin and Plakoglobin in Esophageal Carcinomas and Its Prognostic SignificanceOncology, 1997
- Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagusBritish Journal of Surgery, 1996
- Expression of autocrine motility factor receptor in human esophageal squamous cell carcinomaInternational Journal of Cancer, 1995
- High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosisCancer, 1994
- P53 protein expression and prognosis in squamous cell carcinoma of the esophagusCancer, 1994
- How Cells Cycle Toward CancerScience, 1994
- Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor roleCell, 1991
- Human D-type cyclinCell, 1991
- Cadherin Cell Adhesion Receptors as a Morphogenetic RegulatorScience, 1991